Authors:
Town, T
Tan, J
Sansone, N
Obregon, D
Klein, T
Mullan, M
Citation: T. Town et al., Characterization of murine immunoglobulin G antibodies against human amyloid-beta(1-42), NEUROSCI L, 307(2), 2001, pp. 101-104
Authors:
Mori, T
Nagata, K
Town, T
Tan, J
Matsui, T
Asano, T
Citation: T. Mori et al., Intracisternal increase of superoxide anion production in a canine subarachnoid hemorrhage model, STROKE, 32(3), 2001, pp. 636-642
Authors:
Mori, T
Paris, D
Town, T
Rojiani, AM
Sparks, DL
Delledonne, A
Crawford, F
Abdullah, LI
Humphrey, JA
Dickson, DW
Mullan, MJ
Citation: T. Mori et al., Cholesterol accumulates in senile plaques of Alzheimer disease patients and in transgenic APP(sw) mice, J NE EXP NE, 60(8), 2001, pp. 778-785
Authors:
Tan, J
Town, T
Mori, T
Wu, YJ
Saxe, M
Crawford, F
Mullan, M
Citation: J. Tan et al., CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase, J NEUROSC, 20(20), 2000, pp. 7587-7594
Authors:
Paris, D
Town, T
Mori, T
Parker, TA
Humphrey, J
Mullan, M
Citation: D. Paris et al., Soluble beta-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway, NEUROBIOL A, 21(2), 2000, pp. 183-197
Citation: J. Tan et al., CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway, J BIOL CHEM, 275(47), 2000, pp. 37224-37231
Authors:
Paris, D
Town, T
Humphrey, J
Yokota, K
Mullan, M
Citation: D. Paris et al., Cholesterol modulates vascular reactivity to endothelin-1 by stimulating apro-inflammatory pathway, BIOC BIOP R, 274(2), 2000, pp. 553-558
Authors:
Tan, J
Town, T
Placzek, A
Kundtz, A
Yu, H
Mullan, M
Citation: J. Tan et al., Bcl-x(L) inhibits apoptosis and necrosis produced by Alzheimer's beta-amyloid(1-40) peptide in PC12 cells, NEUROSCI L, 272(1), 1999, pp. 5-8
Authors:
Crawford, F
Town, T
Freeman, M
Schinka, J
Gold, M
Duara, R
Mullan, M
Citation: F. Crawford et al., The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample, NEUROSCI L, 270(3), 1999, pp. 133-136
Authors:
Crawford, F
Freeman, M
Town, T
Fallin, D
Gold, M
Duara, R
Mullan, M
Citation: F. Crawford et al., No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples, NEUROSCI L, 266(3), 1999, pp. 193-196
Authors:
Town, T
Paris, D
Parker, TA
Kundtz, A
Tan, J
Duara, R
Gold, M
Crawford, F
Mullan, M
Citation: T. Town et al., Alzheimers disease is not associated with the hypertension genetic risk factors PLA(2) or G protein beta 3, either independently or interactively with apolipoprotein E, AM J MED G, 88(5), 1999, pp. 465-468
Authors:
Tan, J
Town, T
Paris, D
Mori, T
Suo, ZM
Crawford, F
Mattson, MP
Flavell, RA
Mullan, M
Citation: J. Tan et al., Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation, SCIENCE, 286(5448), 1999, pp. 2352-2355
Authors:
Tan, J
Town, T
Saxe, M
Paris, D
Wu, YJ
Mullan, M
Citation: J. Tan et al., Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10, J IMMUNOL, 163(12), 1999, pp. 6614-6621
Authors:
Paris, D
Town, T
Parker, TA
Tan, J
Humphrey, J
Crawford, F
Mullan, M
Citation: D. Paris et al., Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism, EXP NEUROL, 157(1), 1999, pp. 211-221
Authors:
Mullan, M
Paris, D
Suo, Z
Town, T
Placzek, A
Parker, T
Kundtz, A
Humphrey, J
Crawford, F
Citation: M. Mullan et al., Vasoactivity of soluble A beta peptides - In vitro and in vivo, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 419-427